SIGA Technologies Correlations

SIGA Stock  USD 6.27  0.02  0.32%   
The current 90-days correlation between SIGA Technologies and Esperion Therapeutics is -0.01 (i.e., Good diversification). The correlation of SIGA Technologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

SIGA Technologies Correlation With Market

Very weak diversification

The correlation between SIGA Technologies and DJI is 0.53 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding SIGA Technologies and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in SIGA Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
For information on how to trade SIGA Stock refer to our How to Trade SIGA Stock guide.

Moving together with SIGA Stock

  0.81VALN Valneva SE ADR Downward RallyPairCorr
  0.73VCNX VaccinexPairCorr
  0.65MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.82GMAB Genmab ASPairCorr
  0.73IPSC Century TherapeuticsPairCorr
  0.8KRYS Krystal BiotechPairCorr
  0.75LEGN Legend Biotech CorpPairCorr
  0.87LYRA Lyra TherapeuticsPairCorr
  0.7MDWD MediwoundPairCorr
  0.69NKTX Nkarta IncPairCorr
  0.67NUVB Nuvation BioPairCorr

Moving against SIGA Stock

  0.7BMY Bristol Myers SquibbPairCorr
  0.64VRDN Viridian TherapeuticsPairCorr
  0.64EWTX Edgewise TherapeuticsPairCorr
  0.64GILD Gilead SciencesPairCorr
  0.61KZR Kezar Life SciencesPairCorr
  0.56AMLX Amylyx PharmaceuticalsPairCorr
  0.52MNPR Monopar TherapeuticsPairCorr
  0.51RVMD Revolution MedicinesPairCorr
  0.44AKRO Akero TherapeuticsPairCorr
  0.42SRZN SurrozenPairCorr
  0.41MLYS Mineralys Therapeutics, Downward RallyPairCorr
  0.4PCVX VaxcytePairCorr
  0.4BGNE BeiGenePairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PTPISXTC
CTLTELAN
ALIMINVVY
SHPHSXTC
CPHIINVVY
SHPHPTPI
  
High negative correlations   
SXTCESPR
SHPHALIM
INVVYELAN
SXTCALIM
SHPHESPR
ESPRELAN

Risk-Adjusted Indicators

There is a big difference between SIGA Stock performing well and SIGA Technologies Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze SIGA Technologies' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
ELAN  1.63 (0.19) 0.00 (0.25) 0.00 
 2.87 
 16.54 
INVVY  5.45  0.39  0.04  0.71  7.43 
 13.29 
 49.59 
ESPR  3.44  0.55  0.12  35.80  3.57 
 10.20 
 21.27 
CTLT  0.41 (0.04)(0.23)(0.01) 0.42 
 0.91 
 3.36 
CPHI  4.36  0.33  0.02 (0.21) 4.83 
 10.00 
 43.71 
HCANF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
ALIM  2.74  1.60  0.65 (0.39) 0.37 
 3.28 
 82.36 
SXTC  5.03 (0.94) 0.00  1.69  0.00 
 11.29 
 29.79 
PTPI  3.80 (0.23) 0.00  0.45  0.00 
 6.25 
 45.54 
SHPH  5.75 (0.65) 0.00  0.38  0.00 
 10.08 
 50.96 

SIGA Technologies Corporate Management

Jay MDChief VPProfile
Dennis HrubyChief Scientific Officer and VPProfile
Tove BolkenSenior OfficerProfile
Herb VloedmanSenior OfficerProfile
III MDCEO DirectorProfile
JD EsqGeneral CounselProfile